Pharmathen was founded in 1969 in Athens as a private pharmaceutical company. It focuses on the development and marketing of pharmaceuticals, with an added strong complex generic value. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution.
The company’s human resources include more than 1 000 people who work in the sectors of Research & Development (R&D), production and distribution of drugs to more than 80 countries worldwide. Today, Pharmathen’s products are approved in all EU markets and the distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada.
For more information: www.pharmathen.com